imatinib mesylate has been researched along with Constipation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attia, S; Bauer, S; Becker, C; Blay, JY; Boye, K; Chi, P; Druta, M; Gelderblom, H; George, S; Goldstein, D; Harrow, B; Heinrich, MC; Jones, RL; Kang, YK; Le Cesne, A; Razak, AA; Reichmann, W; Ruiz-Soto, R; Rutkowski, P; Sanchez, C; Serrano, C; Sherman, ML; Siontis, BL; Somaiah, N; Steeghs, N; Trent, J; von Mehren, M; Zalcberg, JR | 1 |
1 trial(s) available for imatinib mesylate and Constipation
| Article | Year |
|---|---|
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.
Topics: Constipation; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Patient Reported Outcome Measures; Quality of Life; Sunitinib | 2023 |